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Background: Whether or not early reperfusion therapy is initiated in Non-STEMI patients is often difficult, because they often present without ST 
segment elevation on the 12 lead admission ECG. Elevated myoglobin levels at admission may improve early detection of Non-STEMI in patients 
presenting with an acute coronary syndrome (ACS). In an all comer ACS population, including ST and non-ST elevation MI, we evaluated the 
incidence of an occluded infarct related vessel (IRV) to elevated baseline myoglobin levels.
Methods: All comer ACS population registry, without exclusion criteria. Admission ECG was evaluated as ST elevation (STEMI) or non ST elevation 
(non-STEMI) by independent core lab. We retrospectively compared admission myoglobin levels (ng/mL) to angio characteristics in the total ACS 
population, as well for the STEMI and Non-STEMI population. Occlusion of IRV was determined as TIMI 0/1 flow.
Results: Between 2005 and 2010: 4909 patients, (66% STEMI, 34% non-STEMI) were admitted. 4067 patients (83%) underwent angiography in 
which an infarct related vessel (IRV) could be determined, 94% in STEMI, 78% in non-STEMI population (p<0.001)
Conclusions: In a large all-comer ACS population, elevated baseline myoglobin increased the incidence of an occluded IRV, especially in patients 
presenting without ST-segment elevation. Diagnostic performance of myoglobin improves the detection of an occluded IRV in Non-STEMI patients.
TIMI 0/1 TIMI 2/3 p-value
Baseline Myoglobin
Total ACS
478 ng/mL(160-1190) 358 ng/mL(114-699) <0.001
Baseline Myoglobin
STEMI
501 ng/mL(161-1238) 490 ng/mL(178-830) 0.092
Baseline Myoglobin
Non-STEMI
307 ng/mL(137-744) 165 ng/mL(71-362) <0.001
